✦ LIBER ✦

Analysis of overall survival from a phase III study of ixabepilone plus capecitabine versus capecitabine in patients with MBC resistant to anthracyclines and taxanes

✍ Scribed by Gabriel N. Hortobagyi; Henry L. Gomez; Rubi K. Li; Hyun-Cheol Chung; Luis E. Fein; Valorie F. Chan; Jacek Jassem; Guillermo L. Lerzo; Xavier B. Pivot; Fernando Hurtado de Mendoza; Binghe Xu; Linda T. Vahdat; Ronald A. Peck; Pralay Mukhopadhyay; Henri H. Roché

Book ID: 106378748
Publisher: Springer US
Year: 2010
Tongue: English
Weight: 272 KB
Volume: 122
Category: Article
ISSN: 0167-6806
DOI: 10.1007/s10549-010-0901-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

2101 ORAL Phase III study of ixabepilone

2101 ORAL Phase III study of ixabepilone plus capecitabine in patients with metastatic breast cancer (MBC) progressing after anthracyclines and taxanes: subgroup analysis of patients receiving ixabepilone in the first-line setting

✍ J. Jassem; E. Thomas; H. Gomez; R.K. Li; H.C. Chung; L.E. Fein; V.F. Chan; R.A. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 76 KB

Ixabepilone plus capecitabine in advance

Ixabepilone plus capecitabine in advanced breast cancer patients with early relapse after adjuvant anthracyclines and taxanes: A pooled subset analysis of two phase III studies

✍ Jacek Jassem; Luis Fein; Mark Karwal; Mario Campone; Ronald Peck; Valerie Poular 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 383 KB

Maintenance of Clinical Efficacy After D

Maintenance of Clinical Efficacy After Dose Reduction of Ixabepilone Plus Capecitabine in Patients With Anthracycline- and Taxane-Resistant Metastatic Breast Cancer: A Retrospective Analysis of Pooled Data From 2 Phase III Randomized Clinical Trials

✍ Vicente Valero; Eduard Vrdoljak; Binghe Xu; Eva Thomas; Henry Gómez; Alexey Mani 📂 Article 📅 2012 🏛 CIG Media Group, LP. 🌐 English ⚖ 405 KB

Ixabepilone plus capecitabine in metasta

Ixabepilone plus capecitabine in metastatic breast cancer patients with reduced performance status previously treated with anthracyclines and taxanes: a pooled analysis by performance status of efficacy and safety data from 2 phase III studies

✍ Henri Roché; Pierfranco Conte; Edith A. Perez; Joseph A. Sparano; Binghe Xu; Jac 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 378 KB

Phase II study of capecitabine and trast

Phase II study of capecitabine and trastuzumab combination chemotherapy in patients with HER2 overexpressing metastatic breast cancers resistant to both anthracyclines and taxanes

✍ Takanori Ishida; Takayoshi Kiba; Motohiro Takeda; Kotone Matsuyama; Satoshi Tera 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 367 KB

An all-oral combination of metronomic cy

An all-oral combination of metronomic cyclophosphamide plus capecitabine in patients with anthracycline- and taxane-pretreated metastatic breast cancer: a phase II study

✍ Zhonghua Wang; Jingsong Lu; Shiangjiin Leaw; Xiaonan Hong; Jialei Wang; Zhimin S 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 223 KB